1. Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology.
- Author
-
Brucki SMD, Adoni T, Almeida CMO, Andrade DC, Anghinah R, Barbosa LM, Bazan R, Carvalho AAS, Carvalho W, Christo PP, Coletta MD, Conforto AB, Correa-Neto Y, Engelhardt E, França Junior MC, Franco C, VON Glehn F, Gomes HR, Houly CGB, Kaup AO, Kowacs F, Kanashiro A, Lopes VG, Maia D, Manreza M, Martinez ARM, Martinez SCG, Nader SN, Neves LO, Okamoto IH, Oliveira RAA, Peixoto FM, Pereira CB, Saba RA, Sampaio LPB, Schilling LP, Silva MTT, Silva ER, Smid J, Soares CN, Sobreira-Neto M, Sousa NAC, Souza LC, Teive HAG, Terra VC, Vale M, Vieira VMG, Zanoteli E, and Prado G
- Subjects
- Brazil, Endocannabinoids, Humans, Cannabinoids, Cannabis, Neurology
- Abstract
Cannabinoids comprehend endocannabinoids, phytocannabinoids, and synthetic cannabinoids, with actions both in the central and peripherical nervous systems. A considerable amount of publications have been made in recent years, although cannabis has been known for over a thousand years. Scientific Departments from the Brazilian Academy of Neurology described evidence for medical use in their areas. Literature is constantly changing, and possible new evidence can emerge in the next days or months. Prescription of these substances must be discussed with patients and their families, with knowledge about adverse events and their efficacy.
- Published
- 2021
- Full Text
- View/download PDF